Interleukin-2 in malignant pleural mesothelioma (and adenocarcinoma of the lung). The use of intrapleural and continuous intravenous infusions: preliminary results.
Citation
Interleukin-2 in malignant pleural mesothelioma (and adenocarcinoma of the lung). The use of intrapleural and continuous intravenous infusions: preliminary results. 1989, 16 Suppl A:161-2 Cancer Treat RevJournal
Cancer Treatment ReviewsPubMed ID
2788503Type
ArticleLanguage
enISSN
0305-7372Collections
Related articles
- Intrapleural administration of interleukin 2 in pleural mesothelioma: a phase I-II study.
- Authors: Goey SH, Eggermont AM, Punt CJ, Slingerland R, Gratama JW, Oosterom R, Oskam R, Bolhuis RL, Stoter G
- Issue date: 1995 Nov
- Intrapleural administration of interleukin-2 for the treatment of patients with malignant pleural mesothelioma: a Phase II study.
- Authors: Karrison TG, Vogelzang NJ
- Issue date: 1999 Aug 1
- 24-hour cyclophosphamide infusion therapy for malignant mesothelioma of the pleura.
- Authors: Anderson H, Hasleton P, Michie AB, Johnson RJ, Thatcher N
- Issue date: 1988 Jan
- Palliative and therapeutic activity of IL-2 immunotherapy in unresectable malignant pleural mesothelioma with pleural effusion: Results of a phase II study on 31 consecutive patients.
- Authors: Castagneto B, Zai S, Mutti L, Lazzaro A, Ridolfi R, Piccolini E, Ardizzoni A, Fumagalli L, Valsuani G, Botta M
- Issue date: 2001 Feb-Mar
- Intrapleural administration of interleukin-2 for the treatment of patients with malignant pleural mesothelioma: a Phase II study.
- Authors: Astoul P, Picat-Joossen D, Viallat JR, Boutin C
- Issue date: 1998 Nov 15